vs
Side-by-side financial comparison of Core Natural Resources, Inc. (CNR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× Core Natural Resources, Inc.). Core Natural Resources, Inc. runs the higher net margin — -7.6% vs -127.8%, a 120.2% gap on every dollar of revenue. On growth, Core Natural Resources, Inc. posted the faster year-over-year revenue change (81.8% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $26.0M). Over the past eight quarters, Core Natural Resources, Inc.'s revenue compounded faster (38.1% CAGR vs 1.3%).
Arch Resources, previously known as Arch Coal, was an American coal mining and processing company. The company mined, processed, and marketed bituminous and sub-bituminous coal with low sulfur content in the United States. Arch Resources was the second-largest supplier of coal in the United States, behind Peabody Energy. As of 2011 the company supplied 15% of the domestic market. Demand came mainly from generators of electricity.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
CNR vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.0B | $1.1B |
| Net Profit | $-79.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | -9.3% | -116.0% |
| Net Margin | -7.6% | -127.8% |
| Revenue YoY | 81.8% | -2.5% |
| Net Profit YoY | -356.3% | -3093.9% |
| EPS (diluted) | $-1.51 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $1.0B | $1.0B | ||
| Q4 24 | $573.6M | $1.1B | ||
| Q3 24 | $553.4M | $1.1B | ||
| Q2 24 | $490.7M | $1.1B | ||
| Q1 24 | $546.7M | $1.1B |
| Q4 25 | $-79.0M | $-1.4B | ||
| Q3 25 | $31.6M | $7.5M | ||
| Q2 25 | $-36.6M | $-8.4M | ||
| Q1 25 | $-69.3M | $-6.4M | ||
| Q4 24 | $30.8M | $-44.4M | ||
| Q3 24 | $95.6M | $-21.0M | ||
| Q2 24 | $58.1M | $-108.4M | ||
| Q1 24 | $101.9M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | -9.3% | -116.0% | ||
| Q3 25 | -1.2% | 7.0% | ||
| Q2 25 | -1.7% | 4.3% | ||
| Q1 25 | -5.3% | 4.5% | ||
| Q4 24 | 6.6% | 10.0% | ||
| Q3 24 | 21.2% | 7.4% | ||
| Q2 24 | 14.6% | -2.5% | ||
| Q1 24 | 22.7% | -5.1% |
| Q4 25 | -7.6% | -127.8% | ||
| Q3 25 | 3.2% | 0.7% | ||
| Q2 25 | -3.3% | -0.8% | ||
| Q1 25 | -6.8% | -0.6% | ||
| Q4 24 | 5.4% | -3.9% | ||
| Q3 24 | 17.3% | -1.9% | ||
| Q2 24 | 11.8% | -10.2% | ||
| Q1 24 | 18.6% | 0.2% |
| Q4 25 | $-1.51 | $-10.23 | ||
| Q3 25 | $0.61 | $0.05 | ||
| Q2 25 | $-0.70 | $-0.06 | ||
| Q1 25 | $-1.38 | $-0.05 | ||
| Q4 24 | $1.04 | $-0.32 | ||
| Q3 24 | $3.22 | $-0.15 | ||
| Q2 24 | $1.96 | $-0.79 | ||
| Q1 24 | $3.39 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $432.2M | — |
| Total DebtLower is stronger | $354.2M | — |
| Stockholders' EquityBook value | $3.7B | $2.9B |
| Total Assets | $6.1B | $8.5B |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $432.2M | — | ||
| Q3 25 | $444.7M | $432.1M | ||
| Q2 25 | $413.2M | $454.2M | ||
| Q1 25 | $388.5M | $409.9M | ||
| Q4 24 | $460.2M | $558.8M | ||
| Q3 24 | $331.7M | $1.5B | ||
| Q2 24 | $216.1M | $542.8M | ||
| Q1 24 | $172.6M | $658.5M |
| Q4 25 | $354.2M | — | ||
| Q3 25 | $334.5M | — | ||
| Q2 25 | $334.0M | — | ||
| Q1 25 | $329.8M | — | ||
| Q4 24 | $94.8M | — | ||
| Q3 24 | $83.7M | — | ||
| Q2 24 | $184.9M | — | ||
| Q1 24 | $185.5M | — |
| Q4 25 | $3.7B | $2.9B | ||
| Q3 25 | $3.8B | $4.4B | ||
| Q2 25 | $3.8B | $4.5B | ||
| Q1 25 | $3.9B | $4.4B | ||
| Q4 24 | $1.6B | $4.3B | ||
| Q3 24 | $1.5B | $4.6B | ||
| Q2 24 | $1.4B | $4.5B | ||
| Q1 24 | $1.4B | $4.7B |
| Q4 25 | $6.1B | $8.5B | ||
| Q3 25 | $6.2B | $10.1B | ||
| Q2 25 | $6.2B | $10.1B | ||
| Q1 25 | $6.3B | $9.8B | ||
| Q4 24 | $2.9B | $9.6B | ||
| Q3 24 | $2.8B | $11.2B | ||
| Q2 24 | $2.7B | $10.4B | ||
| Q1 24 | $2.7B | $10.6B |
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.09× | — | ||
| Q1 25 | 0.08× | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.13× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $107.3M | $175.4M |
| Free Cash FlowOCF − Capex | $26.0M | $148.6M |
| FCF MarginFCF / Revenue | 2.5% | 13.4% |
| Capex IntensityCapex / Revenue | 7.8% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $21.2M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $107.3M | $175.4M | ||
| Q3 25 | $87.9M | $51.7M | ||
| Q2 25 | $220.2M | $75.9M | ||
| Q1 25 | $-109.6M | $-64.5M | ||
| Q4 24 | $121.3M | $312.6M | ||
| Q3 24 | $161.3M | $42.2M | ||
| Q2 24 | $116.3M | $9.5M | ||
| Q1 24 | $77.5M | $-1.4M |
| Q4 25 | $26.0M | $148.6M | ||
| Q3 25 | $38.6M | $29.8M | ||
| Q2 25 | $131.0M | $56.7M | ||
| Q1 25 | $-174.5M | $-90.0M | ||
| Q4 24 | $80.5M | $274.9M | ||
| Q3 24 | $121.9M | $15.1M | ||
| Q2 24 | $60.9M | $-18.9M | ||
| Q1 24 | $35.1M | $-26.5M |
| Q4 25 | 2.5% | 13.4% | ||
| Q3 25 | 3.9% | 2.9% | ||
| Q2 25 | 11.9% | 5.4% | ||
| Q1 25 | -17.1% | -8.6% | ||
| Q4 24 | 14.0% | 24.2% | ||
| Q3 24 | 22.0% | 1.4% | ||
| Q2 24 | 12.4% | -1.8% | ||
| Q1 24 | 6.4% | -2.4% |
| Q4 25 | 7.8% | 2.4% | ||
| Q3 25 | 4.9% | 2.1% | ||
| Q2 25 | 8.1% | 1.8% | ||
| Q1 25 | 6.4% | 2.4% | ||
| Q4 24 | 7.1% | 3.3% | ||
| Q3 24 | 7.1% | 2.5% | ||
| Q2 24 | 11.3% | 2.7% | ||
| Q1 24 | 7.7% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | 2.78× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.94× | — | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 2.00× | — | ||
| Q1 24 | 0.76× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CNR
| Other | $397.4M | 38% |
| Power Generation | $376.5M | 36% |
| PRB | $183.0M | 18% |
| Metallurgical | $42.0M | 4% |
| Industrial | $34.1M | 3% |
| Terminal Revenue | $6.4M | 1% |
| Other Revenue | $3.0M | 0% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |